Robert R Mc Williams, MD

  • 6112 Citations
  • 42 Scopus h-Index
20032019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Robert R Mc Williams is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 10 Similar Profiles
Pancreatic Neoplasms Medicine & Life Sciences
Melanoma Medicine & Life Sciences
Adenocarcinoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
gemcitabine Medicine & Life Sciences
Survival Medicine & Life Sciences
Single Nucleotide Polymorphism Medicine & Life Sciences
Mutation Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2006 2011

Molecular Epidemiology
Pancreatic Neoplasms
Research Personnel
DNA Repair
Neoplasms

Research Output 2003 2019

  • 6112 Citations
  • 42 Scopus h-Index
  • 115 Article
  • 2 Letter
  • 1 Chapter

Case series of dabrafenib-trametinib-induced pyrexia successfully treated with colchicine

Vera, J., Paludo, J., Kottschade, L., Brandt, J., Yan, Y., Block, M. S., Mc Williams, R. R., Dronca, R. S., Loprinzi, C. L., Grothey, A. F. & Markovic, S. N., Jan 1 2019, In : Supportive Care in Cancer.

Research output: Contribution to journalArticle

Colchicine
Fever
Mitogen-Activated Protein Kinases
Familial Mediterranean Fever
Therapeutics
1 Citation (Scopus)

Neoadjuvant vs. adjuvant chemotherapy for cholangiocarcinoma: A propensity score matched analysis

Yadav, S., Xie, H., Bin-Riaz, I., Sharma, P., Durani, U., Goyal, G., Borah, B. J., Borad, M. J., Smoot, R., Roberts, L. R., Go, R. S., Mc Williams, R. R. & Mahipal, A., Jan 1 2019, In : European Journal of Surgical Oncology.

Research output: Contribution to journalArticle

Propensity Score
Cholangiocarcinoma
Adjuvant Chemotherapy
Drug Therapy
Survival

Novel Prognostic Factors in Resected Small Bowel Adenocarcinoma

Huffman, B. M., Jin, Z., Yadav, S., Patel, S., Nagorney, D. M., Truty, M., Mc Williams, R. R., Halfdanarson, T. R. & Mahipal, A., Jan 1 2019, In : Clinical colorectal cancer.

Research output: Contribution to journalArticle

Adenocarcinoma
Survival
Adjuvant Chemotherapy
Monocytes
Neoplasms
13 Citations (Scopus)

Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket study

Meric-Bernstam, F., Hurwitz, H., Raghav, K. P. S., Mc Williams, R. R., Fakih, M., VanderWalde, A., Swanton, C., Kurzrock, R., Burris, H., Sweeney, C., Bose, R., Spigel, D. R., Beattie, M. S., Blotner, S., Stone, A., Schulze, K., Cuchelkar, V. & Hainsworth, J., Apr 1 2019, In : The Lancet Oncology. 20, 4, p. 518-530 13 p.

Research output: Contribution to journalArticle

Colorectal Neoplasms
Therapeutics
Trastuzumab
pertuzumab
Chills
1 Citation (Scopus)

Risk of Different Cancers Among First-degree Relatives of Pancreatic Cancer Patients: Influence of Probands' Susceptibility Gene Mutation Status

Antwi, S., Fagan, S. E., Chaffee, K. G., Bamlet, W. R., Hu, C., Polley, E., Hart, S., Shimelis, H., Lilyquist, J., Gnanaolivu, R. D., Mc Williams, R. R., Oberg, A. L., Couch, F. J. & Petersen, G. M., Mar 1 2019, In : Journal of the National Cancer Institute. 111, 3, p. 264-271 8 p.

Research output: Contribution to journalArticle

Pancreatic Neoplasms
Mutation
Genes
Confidence Intervals
Neoplasms